MIR3662 Gene

HGNC Family Non-coding RNAs
Name microRNA 3662
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR-3662 exhibits context‐dependent functional roles in cancer biology. In lung cancer, particularly non‐small cell lung adenocarcinoma, miR-3662 is upregulated in patient plasma and shows promising diagnostic performance, with its elevated expression correlating with advanced disease stages and tumor subtypes. These findings suggest that miR-3662 holds potential as a liquid biopsy biomarker for early detection and precise classification."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC), miR-3662 appears to act as a tumor suppressor. In HCC, miR-3662 is frequently downregulated, and its enforced expression dampens the Warburg effect by reducing key metabolic parameters—such as lactate production, glucose consumption, ATP generation, and cellular glucose-6-phosphate levels—while enhancing oxygen consumption. Mechanistic studies indicate that miR-3662 directly targets hypoxia-inducible factors such as HIF-1α and the glycolytic enzyme hexokinase 2 (HK2), thereby impairing cell proliferation, invasion, and cell cycle progression. In PDAC, low miR-3662 expression has been implicated in the development of chemoresistance, suggesting its potential utility in overcoming drug resistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "2", "end_ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the hematopoietic compartment, genetic variation at the 6q23.3 locus is associated with increased miR-3662 expression, which in turn promotes colony formation in normal hematopoietic progenitor cells, particularly within the erythroid lineage. Notably, while miR-3662 is virtually absent in acute myeloid leukemia (AML)—where its restoration elicits potent antileukemic effects by directly targeting NF-κB-mediated transcription—its regulatory network in adult T-cell leukemia/lymphoma (ATLL) is driven by transcription factors IRF4 and c-Rel. In ATLL cells, miR-3662 contributes to cell proliferation and is correlated with antiviral drug resistance, underscoring its multifaceted roles in hematologic malignancies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Tomasz Powrózek, Paweł Krawczyk, Dariusz M Kowalski, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.trsl.2015.05.009"}], "href": "https://doi.org/10.1016/j.trsl.2015.05.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26079400"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26079400"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Zhiqiang Chen, Xueliang Zuo, Yao Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-018-0616-8"}], "href": "https://doi.org/10.1038/s41419-018-0616-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29748591"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29748591"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "J Ye, X Xiao, Y Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasma (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4149/neo_2020_190730N689"}], "href": "https://doi.org/10.4149/neo_2020_190730N689"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32726127"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32726127"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "An Liu, Yonggui Zhou, Tian Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiRNA-3662 reverses the gemcitabine resistance in pancreatic cancer through regulating the tumor metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Chemother Pharmacol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00280-021-04289-z"}], "href": "https://doi.org/10.1007/s00280-021-04289-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33993382"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33993382"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Sophia E Maharry, Christopher J Walker, Sandya Liyanarachchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Discov (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2159-8290.CD-16-0023"}], "href": "https://doi.org/10.1158/2159-8290.CD-16-0023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27354268"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27354268"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Kiyoshi Yasui, Mai Izumida, Takeya Nakagawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-3662 expression correlates with antiviral drug resistance in adult T-cell leukemia/lymphoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.04.159"}], "href": "https://doi.org/10.1016/j.bbrc.2018.04.159"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29684346"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29684346"}]}]}]}
Synonyms MIR-3662
NCBI Gene ID 100500880
API
Download Associations
Predicted Functions View MIR3662's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR3662's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR3662's ARCHS4 Predicted Functions.

Functional Associations

MIR3662 has 364 functional associations with biological entities spanning 3 categories (molecular profile, cell line, cell type or tissue, gene, protein or microRNA) extracted from 9 datasets.

Click the + buttons to view associations for MIR3662 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR3662 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR3662 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR3662 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR3662 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR3662 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR3662 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR3662 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR3662 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR3662 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.